Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit.

Front Oncol · 2026 · PMC13222843 · PMID 42232550

Europe PMC DOI

hedged sentence

0.0910

closest p · 1.8× alpha

0.0910

boldest claim

The sentences

did not reach statistical significancep = 0.091so close (0.05 < p ≤ 0.1)

Patients who achieved pCR demonstrated numerically better DFS compared to those without pCR; however, the difference did not reach statistical significance (log-rank p = 0.091).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.